VanEck Biotech ETF
BBH
BBH
82 hedge funds and large institutions have $75.4M invested in VanEck Biotech ETF in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
16
Reduced
28
Closed
14
Calls
$1.82M
Puts
$241K
Net Calls
+$1.58M
Net Calls Change
+$1.01M
Top Buyers
1 |
AL
Aspiriant LLC
Los Angeles,
California
|
+$1.37M |
2 |
PA
Pinnacle Associates
New York
|
+$910K |
3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$741K |
4 |
PSF
Pacific Sun Financial
Los Angeles,
California
|
+$673K |
5 |
Goldman Sachs
New York
|
+$426K |
Top Sellers
1 |
AllianceBernstein
Nashville,
Tennessee
|
-$77.8M |
2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$6.22M |
3 |
CG
Colony Group
Boston,
Massachusetts
|
-$4.9M |
4 |
TC
Trust Company
Manhattan,
Kansas
|
-$4.33M |
5 |
WI
WBI Investments
Red Bank,
New Jersey
|
-$2.61M |